CTRI/2020/06/025960尚未招募未知
A Prospective, randomized, single centred, open labelled, two arm, placebo-controlled trial to evaluate efficacy and safety of Ivermectin drug in patients infected with SARS-CoV-2 virus.
Dr Rajkumar Nikalje0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Symptomatic patients infected with SARS-CoV-2 virus diagnosed on Real time PCR test, admitted to hospital.
排除标准
- •1. Age less than 18 and more 70 years
- •2. Pregnant and lactating women
- •3. Patients not willing to give written informed consent
- •4. Seriously ill patients requiring intensive care
- •5. Known hypersensitivity to Ivermectin drug 6. Subjects who have participated in another investigational drug or research study within 30 days of screening.
- •7. Subjects who are using any medication or has any disease which in the judgment of the Investigator will interfere with the conduct or interpretation of the study.
研究者
相似试验
尚未招募
不适用
Study to evaluate the safety and efficacy of NobiX system.CTRI/2022/05/042448Allevetix Medical Ltd
已完成
不适用
A clinical study, to find out the safety and performance of a medical device (Gastro Duodenal Sleeve) for weight loss in obese type II diabetic patients.CTRI/2017/12/010784Allevetix Ltd10
已完成
不适用
Comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after end of chemotherapyISRCTN17868223Kaohsiung Chang Gung Memorial Hospital61
尚未招募
4 期
To Assess Efficacy and Safety of Zedocef Tablet in URTI PatientsCTRI/2020/09/028124Dr Rajendra Bohra
已完成
不适用
Dente 91 Mom Toothpaste and Mouthwash study on dental health of pregnant females.CTRI/2022/07/044117Dr Faiza Tekrawala30